Dopamine transporter SPECT in patients with mitochondrial disorders

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 1, 2005, Pages 118-120

  Minnerop, M ^a   Kornblum, C ^a   Joe, A Y ^a   Tatsch, K ^b   Kunz, W S ^a   Klockgether, T ^a   Wüllner, Ullrich ^a   Reinhardt, M J ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ARTICLE; BASAL GANGLION; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY CHAIN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRON TRANSPORT COMPLEX I; FEMALE; HUMANS; IODINE RADIOISOTOPES; MELAS SYNDROME; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 10944225098     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.040220     Document Type: Article

References (19)

1. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994;91:6202-10.
2. Lera G, Bhatia K, Marsden CD. Dystonia a s the major manifestation of Leigh's syndrome. Mov Disord 1994;9:642-9.
3. Checcarelli N, Prelle A, Moggio M, et al. Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalomyopathy. J Neurol Sci 1994;23:74-79.
4. Schapira AH, Gu M, Taanman J-W, et al. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann Neurol 1998;44(suppl 1):S89-98.
5. Shoffner JM, Watts RL, Juncos JL, et al. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991;30:332-9.
6. Betarbet R, Sherer TB, MacKenzie G, et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301-6.
7. Langston JW, Ballard P, Tetrud JW, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-80.
8. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988;318:876-80.
9. 123I]β-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996;46:231-7.
10. Berendse HW, Booij J, Francot CMJE, et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol, 2001;50:34-41.
11. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:133-40.
12. Tissingh G, Booij J, Bergmans P, et al. Iodine-123-N-(fluoropropyl- 2β-carbomethoxy-3β-(4-iodophenyl) tropane SPECT in healthy controls and early stage, drug-naive Parkinson's disease. J Nucl Med 1998;39:1143-8.
13. Lavalaye J, Booij J, Reneman L, et al. Effect of age and gender on dopamine transporter imaging with [123]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 2000;27:867-9.
14. Schröder R, Vielhaber S, Wiedemann FR, et al. New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle. J Neuropathol Exp Neurol 2000;59:353-60.
15. 123I]-FP-CIT study group. Mov Disord 2000;15:503-10.
16. Radau P, Koch W, Holtmannspoetter M, et al. Automated, objective software for 3D registration and analysis of dopomine transporter SPECT studies. J Nucl Med 2003;44(suppl):12.
17. Bosbach S, Kornblum C, Schröder R, et al. Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Brain 2003;126:1231-40.
18. Moslemi AR, Melberg A, Holme E, et al. Autosomal dominant progressive external ophthalmoplegia-distribution of multiple mitochondrial DNA deletions. Neurology 1999;53:79-84.
19. Taylor CA, Saint-Hilaire MH, Cupples LA, et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999;88:742-9.